We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Complement C3a receptor-mediated vascular dysfunction: a complex interplay between aging and neurodegeneration.
- Authors
Bhatia, Kanchan; Ahmad, Saif; Kindelin, Adam; Ducruet, Andrew F.
- Abstract
Vascular dysfunction resulting in compromised blood-brain barrier (BBB) integrity is evident in aging and disease. Although the complement C3a/C3a receptor (C3a/C3aR) axis influences normal brain aging and disease progression, the mechanisms governing endothelial C3aR-mediated neurovascular inflammation and BBB permeability remain unexplored. In this issue of the JCI, Propson et al. investigated endothelial C3a/C3aR signaling in normal, aged, and neurodegenerative mouse models. Endothelial C3aR signaling modulated age-dependent increases in VCAM1, initiated peripheral lymphocyte infiltration, and enhanced microglial activity. Increased calcium release downstream of C3aR signaling disrupted the vascular endothelial cadherin (VE-cadherin) junctions, increased BBB permeability, and degraded vascular structure and function. Mice lacking C3aR (C3ar1-/-) and mice treated with a C3aR antagonist showed attenuated age-related microglial reactivity and neurodegeneration. These results confirm that complement-mediated signaling impacts vascular health and BBB function in normal aging and neurodegenerative disease, suggesting that complement inhibitors represent a therapeutic option for cerebral microvascular dysfunction.
- Subjects
COMPLEMENT receptors; AGE factors in disease; COMPLEMENT inhibition; NEURODEGENERATION; RESEARCH; ANIMAL experimentation; RESEARCH methodology; CELL receptors; MEDICAL cooperation; EVALUATION research; CELLULAR signal transduction; COMPARATIVE studies; MICE
- Publication
Journal of Clinical Investigation, 2021, Vol 131, Issue 1, p1
- ISSN
0021-9738
- Publication type
journal article
- DOI
10.1172/JCI144348